Related Experiment Video
Updated: Jun 24, 2026
05:30
Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
Published on: August 8, 2025
Mediastinal hemangiopericytoma
Youko Horikawa-Kyo1, Takeo Tanaka, Hirofumi Tanano
1Department of Pediatrics, National Hospital Organization Kure Medical Center, Kure City, Hiroshima, Japan.
Pediatric Blood & Cancer
|April 15, 2009
Summary
Mediastinal hemangiopericytoma (HPC) is a rare pediatric tumor. This case study shows a 3-year-old patient successfully treated with surgery, radiation, and chemotherapy, remaining disease-free for 6 years.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Radiation Oncology
Background:
- Mediastinal hemangiopericytoma (HPC) is an uncommon tumor in pediatric patients.
- Limited clinical data exist for managing childhood HPC, particularly in the mediastinum.
Observation:
- A 3-year-old female presented with a mediastinal hemangiopericytoma.
- The initial surgical resection was incomplete, necessitating further treatment.
Findings:
- The patient received adjuvant radiation therapy and chemotherapy following incomplete surgical resection.
- The patient achieved a complete remission and remains alive without adverse events 6 years post-diagnosis.
Implications:
- This case highlights the potential efficacy of multimodal treatment for pediatric mediastinal HPC.
- Successful outcomes in rare pediatric tumors underscore the importance of tailored therapeutic strategies.
